Nogo-B Promotes Angiogenesis in
. Samples with obvious bleeding were excluded. Vitreous samples were immediately centrifuged at 15, 000g for 20 min at 4°C and the supernatants were stored at −80°C until use. Six fibrovascular samples were surgically removed from the PDR eyes and were used in immunohistochemistry and Immunofluorescence.
Immunohistochemistry Fibrovascular samples were fixed in 4% paraformaldehyde and embedded in paraffin. The fixed sections were stained with Nogo-B antibody (abcam, Cambridge, USA). Nuclei were counterstained with hematoxylin and sections were visualized with light microscopy.
ELISA assay for Nogo-B and VEGF
Concentrations of Nogo-B in vitreous humor was measured using human soluble Nogo-B elisa kit (Biolegend, San Diego, CA) according to the manufacturer's instruction as previously described [24] . Concentrations of in the cell supernatant was measured by human VEGF ELISA kit (R&D, Minneapolis, USA). Assays were performed in three replicated wells and each experiment was repeated three times independently.
Immunofluorescence
Paraffin sections of fibrovascular samples were deparaffinised and hydrated by exposure to xylene and graded alcohols followed by water. And microwave-based antigen retrieval was performed in 10 mmol/l citrate buffer (pH = 6). Then sections were probed with Nogo-B (abcam, Cambridge, USA) and CD31 (abcam, Cambridge, USA). The secondary antibodies used for fluorescence detection were Alexa Fluor 488 and 555 (Invitrogen, Carlsbad, USA). Sections were visualised under microscopy.
Lentiviral vector transduction
Both Lenti-NogoB-RNAi and Lenti-NC were constructed and producted by Genechem (Shanghai, China). 2 × 10 5 HRMECs were plated in each well of a 6-well-plate. When the cells reached 20% to 30% confluence, lentiviral vector expressing siRNA-NogoB (5'-3': CACAGAAUCUAUGGACUGAAU) and negative control (5'-3': UUCUCCGAACGUGUCACGUTT) was added (MOI=10) with 50 μg/mL Polybrene (Genechem, Shanghai, China). After incubation for 8 hours, the media replaced with complete culture media. Transduced cell clones were selected with 3 μg/mL puromycin (Genechem, Shanghai, China) for 2 weeks, and cells were expanded in complete culture medium. HMERCs (2 × 10 4 cells/well) were seeded into 96-well plates. After attachment, cells were incubated with different glucose for 48 hours. Cell viability was determined by CCK-8 (Dojindo, Rockville, USA). The optical density values at 450 nm were quantified by a microplate reader (BioTek, Winooski, USA). Assays were performed in three replicated wells and each experiment was repeated three times independently.
CCK-8 assay

Wound closure assay
Confluent monolayers of HRMECs were wounded using a micropipette tip (200 μL tip), rinsed with PBS to remove detached cells, and incubated with cell culture medium without fetal bovine serum. Wound closure was monitored after 24 hours and photographed under inverted microscope.
Cell migration assay
HRMECs (1 × 10 5 cells/well) were seeded into the upper chamber of the transwells, and then high D-glucose (25 mM) or L-glucose (25 mM) was added into the lower chamber. After 12 hours, the nonmigrated cells were wiped off with a cotton swab, and the filters were fixed with 4% paraformaldehyde for 20 minutes before stained by crystal violet (Beyotime, Shanghai, China). Images were pictured under the inverted microscope.
Tube formation assay HRMECs (1 × 10 5 cells/well) were starved in endothelial cell medium containing 0.1% fetal bovine serum for 8 hours, and then incubated with different glucose for 48 hours. Cells were seeded into 24-well plates precoated with matrigel (BD Biosciences, Maryland, USA), and treated in different glucose for another 6 hours. Images were pictured under the inverted microscope.
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Western-blot analysis Protein samples were separated by SDS-PAGE and blots were probed with an appropriate combination of primary and secondary antibodies. The bands were identified by enhanced chemiluminescence kits and visualized using the Amersham Image 600 System. Primary antibodies were antibodies to Nogo-B (Abcam, Cambridge, USA), PI3K p85(Cell Signaling Technology, Danvers, USA), PI3K p-p85 (Cell Signaling Technology, Danvers,USA), Akt (Cell Signaling Technology, Danvers,USA), p-Akt (Cell Signaling Technology, Danvers,USA), GAPDH (Santa Cruz,Dallas,USA). All the second antibodies were obtained from Calbiochem.
Co-culture system First, HRMECs infected by lentivirus were cultured on transwell inserts (NC and LV group), and D-glucose (25 mM) was added to both of the inserts. After 48 hour treatment, the cell supernants was collected, and fresh complete growth medium with normal D-glucose was added for further culture. Then normal HRMECs were seeded to the bottom wells of chamber for addtional 24 hours to test their ability of angiogenesis and both the supernants and cells were collected for subsequently examination (symboled NC-f and LV-f group).
Statistical analysis
Statistical analyses were performed using the SPSS version 20.0. Data were expressed as means ± standard error of the mean or median with interquattile range. The significance of differences between groups was evaluated by two-tailed student's t-test, non-parametric tests and one-way ANOVA test, and P < 0.05 was considered as statistically significant differences.
Results
Nogo-B was highly expressed in human PDR tissues
Since no studies on Nogo-B expression in human ocular tissue have been reported, first, using assays of immunohistochemisty, we confirmed the expression of Nogo-B in fibrovascular tissues surgically excised from human eyes (Fig. 1a) . Next, ELISA analysis on vitreous humor suggested that the expression of Nogo-B in PDR patients was considerably higher than MH and RRD patients (Fig. 1b) . Further, doublestaining experiments of fibrovascular tissue samples demonstrated colocalization of Nogo-B signal with CD31, a vascular endothelial cell marker, showing that Nogo-B protein could be produced by vascular endothelial cells (Fig. 1c) . (Fig. 2e) .
Downregulation of Nogo-B attenuated high glucose-induced angiogenesis in HRMECs
As high D-glucose promoted Nogo-B expression, we studied the effects of Nogo-B in high glucose-induced angiogenesis using lentivirus downregulating Nogo-B (LV-siNogoB) in HRMECs. Compared with negative control of lentivirus (NC group), downregulating of Nogo-B partially reversed high D-glucose (25 mM) induction of migration and tube formation in HRMECs as indicated from scar assays, transwell assay and tube formation assay (Fig. 3b-g ). However, downregulation of Nogo-B didn't affect the proliferation rate of HRMECs from CCK-8 assay (Fig. 3a) .
Downregulation of Nogo-B blocked high glucose-induced activation of VEGF/PI3K/Akt pathway in HRMECs
Previous studies revealed that activation of the PI3K/Akt pathway was crucial for VEGF induced angiogenesis, including cell survival, migration and tube formation [27] [28] [29] [30] . To elucidate the underlying mechanisms for Nogo-B to affect angiogenisis of HRMECs, we 
The cell viability was quantified and presented as a histogram by CCK-8 assay after treatment with D-glucose (25 mM) for 48 hours, n = 3 in each group (a). The migration rate was determined in scratch wound assay, n=3 in each group (b, c) and transwell assay, n=3 in each group (d, e). The tube formation ability was assesed by plating the cells on matrigel, n = 3 in each group (f, g). The expression of Nogo-B infected by lentivirus was detected by western blot (h). Data were shown as mean ± SEM, **, P<0.01 by student's t-test. (Fig. 4b, c) . Recently Nogo-B was shown to inhibit the sphingolipid de novo biosynthesis [22] . Ceramide, a central metabolite of this pathway, has been shown to decrease the activation of the Akt pathway [31] . So we used myriocin to inhibit sphingolipid biosynthesis in Nogo-B knock down HRMECs. It was shown that the rate of migration and tube formation, as well as Akt activation in LV group was increased after myriocin pretreatment (Fig. 5) .
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High glucose treatment promoted the secretion of Nogo-B and presented as a "long-term memory"
Since western blotting of cell extracts from high D-glucose treatment indicated the elevated expression of Nogo-B, we next tested whether high glucose induced upregulation of Nogo-B could be released. ELISA analysis of cell supernants reflected that HRMECs exposed to high D-glucose for 48 hours induced notable secretion of Nogo-B, compared with L-glucose groups and normal D-glucose control (Fig. 6a) . Interestingly, after 48 hour treatment of high D-glucose followed by fresh complete growth medium with normal D-glucose of additional 24 hours, Nogo-B was still apparently detectable and was much more sereted in the high D-glucose group (Fig. 6b ). Next, we tested whether this phenomenon could be observed 
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Cellular Physiology and Biochemistry the lower cells under LV group (LV-f group) showed blunted ability of migration and tube formation compared with the downside cells under NC group (NC-f group). However, the proliferation rate was not affected (Fig. 7a-g ). Besides, PI3k p85 and Akt was activated in NC-f group compared with LV-f group (Fig. 7h, i) .
Discussion
PDR, the stage of abnormal newly formed blood vessels grow from the retina, results in subsequntely tractional retinal detachment and hemorrhage, is the major concerning problem of DR [32, 33] . Although the underlying mechanisms of aberrant angiogenesis in PDR is less than completely understood, lines of evidence shows that hyperglycemia is the most influential factor that contributes to the angiogenesis [34, 35] . Nogo-B, one of the evolutionary conservative proteins of endoplasmic reticulum that primarily play a role in promoting membrane curvature and tubules maintenance, was reported as a regulator of vascular remodeling and blood pressure, suggesting its role in vasvluar function [21, 22, 36, 37] . However, the role and function of Nogo-B in angiogenesis, especially in PDR have not been established yet. Therefore, we initially evaluated the presence of Nogo-B in the human PDR tissues and HRMECs in vitro. Strikingly, Nogo-B was enriched in both the vitreous and fibrovascular tissue samples of PDR patients. And stimulating of HRMECs with high glucose To get insights into the participation of Nogo-B in angiogenesis of PDR, we use high glucose stimulation of HRMECs, an established cell culture model [5, 38] . The cell proliferation assay, cell migration assay and tube formation assay are mature methods to imitate three Fig. 7 . Nogo-B promoted angiogenesis through PI3K/Akt activation in co-culture system. We established coculture system as described in methods, after fresh cell culture medium with normal glucose replacement, the lower cells under HRMECs infected by lentivrus were symboled as LV-f group and NC-f group. The cell viability was quantified and presented as a histogram by CCK-8 assay after treatment, n = 3 in each group (a). The migration rate was determined in scratch wound assay, n = 3 in each group (b, c) and transwell assay, n = 3 in each group (d, e). The tube formation ability was assesed by plating the cells on matrigel, n = 3 in each group (f, g). Activation of PI3K p85 and Akt was detected using western blot (h, i). Data were shown as mean ± SEM, **, P<0.01 by student's t-test.
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Cellular Physiology and Biochemistry critical steps of angiogenesis process. High glucose stimilation of HRMECs, which is the major target of hyperglycemia for its location of inner wall in blood vessel [39] , resulted in considerable promotion of proliferation, migration and tube formation in HRMECs. And high glucose-induced angiogenesis was partialy reversed through downregulation of Nogo-B. The results suggested a novel aspect for the role of Nogo-B in high glucose condition for HRMECs as a positive regulator of angiogenesis, which was consistant with the previous reports demonstrated that Nogo-B promoted migration of HUVECs [21] . The underlying molecular mechanism of diabetic retinopathy is complex and remains largely elusive, which includes PI3K/Akt, p38 MAP kinase, calcium/calmodulin dependent protein kinase a, NOTCH/Wnt signalling [40] [41] [42] . Among them, an active VEGF/PI3K/Akt pathway has been dominated linked to pathological angiogenesis in PDR [28, 43, 44] . To analysis the molecular mechanisms and mediators of Nogo-B in regulation of angiogenesis, we examined VEGF secretion, as well as PI3K and Akt activation in lentivirus infected HRMECs. Our results showed that HRMECs exposed in high glucose elicited substantially activation of PI3K and Akt, and stimulated VEGF secretion, which was in consistant with accumulating previous reports [27, 28, 43] . In addition, downregulation of Nogo-B considerably blocked high glucose induced VEGF secretion, PI3K and Akt activation in HRMECs, indicating that Nogo-B may exert its angiogenesis actions through VEGF/PI3K/Akt pathway. Recently Nogo-B was reported to inhibit the sphingolipid biosynthesis through weakening the activity of serine palmitoyltransferase, the rate-limiting enzyme of the pathway [22] . Ceramide, a central metabolite of this pathway, was significantly upregulated in the absense of Nogo-B and has been shown to induce an inhibition of Akt activation [22, 31, 45] . Our results showed that myriocin, an inhibitor of sphingolipid biosynthesis, partially rescued the impairment of angiogenesis and Akt activation in Nogo-B knock down HRMECs. However, the underlying mechanisms remained largely speculative and we will investigate further in our future study.
Considering the cell surface location of Nogo-B in endothelial cells and the extracellular domains exposed and released upon injury [21] , we examined whether Nogo-B could be released to cell culture medium upon high glucose stimulation. Surprisingly, the relatively detectable of Nogo-B after exposure to high glucose was found in the present study. Besides, after a subsequent 24 hours of normal glucose culture, it was still apparently detectable in the cluture medium. To verify the role of Nogo-B in this phenomenon, we used co-cluture system with the upper chamber cultured with lentivrus infected HRMECs and normal HRMECs in the lower wells afterward, and added high glucose to the inserts. We found the secretion of Nogo-B persited after replacement of fresh medium for 24 hours, and the elevated Nogo-B in supernants could still promote angiogenesis of normal HRMECs in the downside chamber. These data indicated that HRMECs affected by high glucose could communicate with its neighboring normal cells through Nogo-B, which may contribute to the signalling cascade amplification of hyperglycemia in DR.
Conclusion
We reported that Nogo-B was highly enriched in ocular tissues of PDR patients and in HRMECs exposed to high glucose, and Nogo-B could be secreted upon high glucose exposure and acted as a positive regulator of angiogenesis in HRMECs partially through VEGF/PI3K/ Akt pathway, and the cell to cell communication between impaired HRMECs and neighboring normal cells could be ascribed to "the high glucose-induced elevation of Nogo-B memory". Therefore, elucidation of novel ways to downregulate the retinal level of Nogo-B or prevent its release can be a feasible therapeutic strategy for treating angiogenesis of PDR.
Cellular Physiology and Biochemistry
Cellular Physiology and Biochemistry
